頁面路徑選單
Healthcare BPO Market Payer (Claims Processing, HR Services, Finance & Accounts), Provider (Medical Billing & Coding) & Pharmaceutical (Clinical Trial, Contract Manufacturing, & Non-Clinical Services) - Trends & Forecasts (2013 - 2018)
出 版 商：MarketsandMarkets
出版日期：2014/01/09
頁 數：479頁
文件格式：PDF
價 格：
USD 4,650 (Single-User License)
USD 5,650 (Multi-User License)
USD 7,150 (Global-User License)
USD 5,650 (Multi-User License)
USD 7,150 (Global-User License)
Business Process Outsourcing (BPO) has emerged as an important service offering in the healthcare industry; rapid growth in the global healthcare industry has fueled the growth of the healthcare BPO market. The market has evolved and multiple service offerings have emerged in order to meet the needs of the healthcare industry.
The Global Healthcare BPO Market report provides market size and segmentation of this market. In this report, the global healthcare BPO market has been categorized into three segments, namely, payer outsourcing, provider outsourcing, and pharmaceutical outsourcing. Each of these segments is further divided into appropriate service segments. The payer outsourcing segment has been categorized into claims processing, HR services, member services/customer care, and finance and accounts segments. The provider outsourcing segment has been categorized into medical billing, medical coding, medical transcription, and finance and accounts segments. The pharmaceutical outsourcing segment has been categorized into clinical research organizations (CROs), contract manufacturing organizations (CMOs), and business support services segments. This report provides definitions, market shares, and analyst insights on each of these segments. Also, this report includes an exhaustive value analysis for all these segments for 2011, 2012, and 2013.
Market forecast for all segments till 2018 is provided. The report includes geographic segmentation of the global healthcare BPO market. Moreover, it identifies important source and destination geographies for the global healthcare BPO market. The source geography segments present in this report are the U.S., Europe, and Rest of the World, while the destination geography segments present in this report are India, China, U.S., Europe, Philippines, LATAM, Middle East, and Rest of the World.
Company profiles of important organizations in this market are included in this report. These profiles include financial information, service portfolios, and recent developments in the organizations. This report further includes information about mergers and acquisitions, agreements and partnerships, new product launches, and partnerships in this market.
Reasons to Buy the Report:
‧ Comprehensive information on service offerings in payer, provider, and pharmaceutical outsourcing markets, including definitions, market shares, and growth prospects of service segments in each outsourcing market
‧ Value estimates for source and destination geographies for each service segment
‧ Growth drivers, restraints, opportunities, and insights for each service segment
‧ Comprehensive information on service portfolios, financial information, recent developments, and growth strategies of top players in the healthcare BPO market
The Global Healthcare BPO Market report provides market size and segmentation of this market. In this report, the global healthcare BPO market has been categorized into three segments, namely, payer outsourcing, provider outsourcing, and pharmaceutical outsourcing. Each of these segments is further divided into appropriate service segments. The payer outsourcing segment has been categorized into claims processing, HR services, member services/customer care, and finance and accounts segments. The provider outsourcing segment has been categorized into medical billing, medical coding, medical transcription, and finance and accounts segments. The pharmaceutical outsourcing segment has been categorized into clinical research organizations (CROs), contract manufacturing organizations (CMOs), and business support services segments. This report provides definitions, market shares, and analyst insights on each of these segments. Also, this report includes an exhaustive value analysis for all these segments for 2011, 2012, and 2013.
Market forecast for all segments till 2018 is provided. The report includes geographic segmentation of the global healthcare BPO market. Moreover, it identifies important source and destination geographies for the global healthcare BPO market. The source geography segments present in this report are the U.S., Europe, and Rest of the World, while the destination geography segments present in this report are India, China, U.S., Europe, Philippines, LATAM, Middle East, and Rest of the World.
Company profiles of important organizations in this market are included in this report. These profiles include financial information, service portfolios, and recent developments in the organizations. This report further includes information about mergers and acquisitions, agreements and partnerships, new product launches, and partnerships in this market.
Reasons to Buy the Report:
‧ Comprehensive information on service offerings in payer, provider, and pharmaceutical outsourcing markets, including definitions, market shares, and growth prospects of service segments in each outsourcing market
‧ Value estimates for source and destination geographies for each service segment
‧ Growth drivers, restraints, opportunities, and insights for each service segment
‧ Comprehensive information on service portfolios, financial information, recent developments, and growth strategies of top players in the healthcare BPO market
Table Of Contents
1 Introduction (Page No. - 26)
1.1 Key Take-Aways
1.2 Report Description
1.3 Market Segments and Market Aspects Covered
1.4 Stakeholders
1.5 Report Assumptions
1.5.1 General Assumptions
1.5.2 Forecast Assumptions
1.6 Research Methodology
1.6.1 Market Size Estimation
1.6.2 Data Triangulation
1.6.3 Market Forecasting Model
1.6.4 Key Data Points Taken From Secondary Sources
1.6.5 Key Data Points Taken From Primary Sources
2 Executive Summary (Page No. - 33)
3 Healthcare BPO Market Overview (Page No. - 37)
3.1 Introduction
3.2 History and Evolution
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Introduction of the Patient Protection and Affordable Care Act (Ppaca)
3.3.1.2 Need To Reduce Rising Healthcare Costs
3.3.1.3 Shortage of Skilled Personnel
3.3.2 Restraints
3.3.2.1 Unforeseen Costs
3.3.2.2 Confidentiality and Security of Data Is A Major Concern
3.3.2.3 Loss of Managerial Control
3.3.3 Opportunities
3.3.3.1 Consolidation of the U.S. Healthcare System
3.3.3.2 Icd-10 Conversion
3.4 Market Share
3.5 Porter’s Five Forces Analysis
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Threat From New Entrants
3.5.4 Threat From Substitutes Services
3.5.5 Degree of Competition
3.5.6 Overall Porter’s Analysis
4 Healthcare Payer Outsourcing Market (Page No. - 48)
4.1 Introduction
4.1.1 Drivers
4.1.1.1 Ppaca Will Add Approximately 30 Million Individuals To the American Insurance
4.1.2 Restraints
4.1.2.1 Errors During Client Interaction Could Affect A Company’s Reputation
4.1.3 Opportunities
4.1.3.1 Vendors With Complete Range of Services Attract Insurance Providers
4.2 Claims Processing
4.2.1 Claims Indexing
4.2.2 Claims Investigation
4.2.3 Claims Adjudication
4.2.4 Claims Repricing
4.2.5 Claims Settlement
4.2.6 Litigation Management
4.2.7 Information Management
4.3 Hr Services
4.4 Member Services/Customer Care
4.5 Finance & Accounts
5 Healthcare Provider Outsourcing Market (Page No. - 80)
5.1 Introduction
5.1.1 Drivers
5.1.1.1 Domain Knowledge Helps in Increasing Revenue
5.1.1.2 Increasing Safety of the Processes
5.1.2 Restraints
5.1.2.1 Deteriorating Quality of Service
5.1.2.2 Privacy & Security Concerns
5.1.3 Opportunities
5.1.3.1 Teleradiology
5.1.3.2 Medical Graphics
5.2 Medical Billing
5.3 Medical Coding
5.4 Medical Transcription
5.5 Finance & Accounts
6 Pharmaceutical Outsourcing Market (Page No. - 99)
6.1 Introduction
6.1.1 Drivers
6.1.1.1 Rising Costs and Decreasing Productivity Are Compelling Pharmaceutical Companies To Outsource
6.1.1.2 off-Patenting of Drugs Will Drive the Outsourcing Market
6.1.1.3 Desire To Gain Access To New Technologies, One of the Key Drivers
6.1.1.4 Strategy To Concentrate on Core Competencies & High Margin Products Compels Companies To Outsource
6.1.1.5 Emergence of Biologics To Be One of the Major Drivers in the Future
6.1.2 Restraints
6.1.2.1 Quality Control Issues Limit Outsourcing
6.1.2.2 Differences in the East/West Disease Profiles Inhibits Outsourcing To Specific Regions
6.1.3 Opportunities
6.1.3.1 Outsourcing of Supply Chain & Logistics
6.1.3.2 Outsourcing of Sales & Marketing Functions
6.1.3.3 Outsourcing Medical Writing & Regulatory Functions, A Major Opportunity
6.1.3.4 Emergence of Biologics As A Major Opportunity in the Future
6.2 Cro Market
6.2.1 Drug Discovery
6.2.2 Pre-Clinical
6.2.3 Phase I Clinical
6.2.4 Phase Ii Clinical
6.2.5 Phase Iii Clinical
6.2.6 Phase Iv Clinical
6.2.7 Cdm & Biostatistics
6.2.8 Medical Writing
6.2.9 Regulatory Services
6.2.10 Other Cro Services
6.3 Cmo Market
6.3.1 Api Manufacturing
6.3.2 Formulation & Packaging
6.4 Non-Clinical Services
6.4.1 Scm & Logistics
6.4.2 Sales & Marketing
6.4.2.1 Marketing Kpo/Sales Analytics
6.4.3 Other Non-Clinical Functions
7 Healthcare BPO Market, Geographical Analysis (Page No. - 156)
7.1 Source Geography
7.1.1 U.S.
7.1.1.1 Payer & Provider
7.1.1.2 Pharmaceutical
7.1.2 Europe
7.1.2.1 Payer & Provider
7.1.2.2 Pharmaceutical
7.1.3 Row
7.2 Destination Geography
7.2.1 U.S.
7.2.1.1 Payer & Provider
7.2.1.2 Pharmaceutical
7.2.2 India
7.2.2.1 Payer & Provider
7.2.2.2 Pharmaceutical
7.2.3 Europe
7.2.3.1 Payer & Provider
7.2.3.2 Pharmaceutical
7.2.4 Other Destination Geographies
7.2.4.1 China
7.2.4.2 Philippines
7.2.4.3 Latam
7.2.4.4 Middle East
7.2.4.5 Row
8 Competitive Landscape (Page No. - 209)
8.1 Introduction
8.2 Partnerships, Agreements, Strategic Alliances, and Collaborations
8.3 Expansions
8.4 Acquisitions
8.5 New Product/Service Launches
8.6 Others
9 Healthcare BPO Market, Company Profiles (Page No. - 294)
9.1 Accenture Plc
9.1.1 Overview
9.1.2 Financials
9.1.3 Services
9.1.4 Strategy
9.1.5 Developments
9.2 Accretive Health, Inc.
9.2.1 Overview
9.2.2 Financials
9.2.3 Services
9.2.4 Strategy
9.2.5 Developments
9.3 Anthelio Healthcare Solutions, Inc.
9.3.1 Overview
9.3.2 Financials
9.3.3 Services
9.3.4 Strategy
9.3.5 Developments
9.4 Boehringer Ingelheim Gmbh
9.4.1 Overview
9.4.2 Financials
9.4.3 Services
9.4.4 Strategy
9.4.5 Developments
9.5 Catalent Pharma Solutions, Inc.
9.5.1 Overview
9.5.2 Financials
9.5.3 Services
9.5.4 Strategy
9.5.5 Developments
9.6 Charles River Laboratories International, Inc.
9.6.1 Overview
9.6.2 Financials
9.6.3 Products & Services
9.6.4 Strategy
9.6.5 Developments
9.7 Cognizant Technology Solutions Corporation
9.7.1 Overview
9.7.2 Financials
9.7.3 Services
9.7.4 Strategy
9.7.5 Developments
9.8 Covance, Inc.
9.8.1 Overview
9.8.2 Financials
9.8.3 Services
9.8.4 Strategy
9.8.5 Developments
9.9 Gebbs Healthcare Solutions, Inc.
9.9.1 Overview
9.9.2 Financials
9.9.3 Products & Services
9.9.4 Strategy
9.9.5 Developments
9.10 Genpact Limited
9.10.1 Overview
9.10.2 Financials
9.10.3 Services
9.10.4 Strategy
9.10.5 Developments
9.11 Ibm Corporation
9.11.1 Overview
9.11.2 Financials
9.11.3 Services
9.11.4 Strategy
9.11.5 Developments
9.12 Icon Plc
9.12.1 Overview
9.12.2 Financials
9.12.3 Services
9.12.4 Strategy
9.12.5 Developments
9.13 Infosys Bpo Limited
9.13.1 Overview
9.13.2 Financials
9.13.3 Services
9.13.4 Strategy
9.13.5 Developments
9.14 Igate Patni
9.14.1 Overview
9.14.2 Financials
9.14.3 Products & Services
9.14.4 Strategy
9.14.5 Developments
9.15 Inventiv Health Inc
9.15.1 Overview
9.15.2 Financials
9.15.3 Products & Services
9.15.4 Strategy
9.15.5 Developments
9.16 Lonza Group Ltd.
9.16.1 Overview
9.16.2 Financials
9.16.3 Services
9.16.4 Strategy
9.16.5 Developments
9.17 Medusind Solutions Inc
9.17.1 Overview
9.17.2 Financials
9.17.3 Products & Services
9.17.4 Strategy
9.17.5 Developments
9.18 Mphasis Limited
9.18.1 Overview
9.18.2 Financials
9.18.3 Products & Services
9.18.4 Strategy
9.18.5 Developments
9.19 Omega Healthcare Management Services Pvt Ltd
9.19.1 Overview
9.19.2 Financials
9.19.3 Products & Services
9.19.4 Strategy
9.19.5 Development
9.20 Parexel International Corporation
9.20.1 Overview
9.20.2 Financials
9.20.3 Services
9.20.4 Strategy
9.20.5 Developments
9.21 Patheon Inc
9.21.1 Overview
9.21.2 Financials
9.21.3 Products & Services
9.21.4 Strategy
9.21.5 Developments
9.22 Pharmaceutical Product Development, Inc.
9.22.1 Overview
9.22.2 Financials
9.22.3 Products & Services
9.22.4 Strategy
9.22.5 Developments
9.23 Piramal Enterprises Limited
9.23.1 Overview
9.23.2 Financials
9.23.3 Products & Services
9.23.4 Strategy
9.23.5 Developments
9.24 Quintiles Transnational Holdings, Inc.
9.24.1 Overview
9.24.2 Financials
9.24.3 Services
9.24.4 Strategy
9.24.5 Developments
9.25 Tata Consultancy Services Ltd
9.25.1 Overview
9.25.2 Financials
9.25.3 Products & Services
9.25.4 Strategy
9.25.5 Developments
9.26 Tech Mahindra
9.26.1 Overview
9.26.2 Financials
9.26.3 Products & Services
9.26.4 Strategy
9.26.5 Developments
9.27 Teleradiology Solutions Pvt Ltd.
9.27.1 Overview
9.27.2 Financials
9.27.3 Products & Services
9.27.4 Strategy
9.27.5 Developments
9.28 Wns (Holdings) Limited
9.28.1 Overview
9.28.2 Financials
9.28.3 Services
9.28.4 Strategy
9.28.5 Developments
9.29 Xerox Corporation
9.29.1 Overview
9.29.2 Financials
9.29.3 Products & Services
9.29.4 Strategy
9.29.5 Developments
1 Introduction (Page No. - 26)
1.1 Key Take-Aways
1.2 Report Description
1.3 Market Segments and Market Aspects Covered
1.4 Stakeholders
1.5 Report Assumptions
1.5.1 General Assumptions
1.5.2 Forecast Assumptions
1.6 Research Methodology
1.6.1 Market Size Estimation
1.6.2 Data Triangulation
1.6.3 Market Forecasting Model
1.6.4 Key Data Points Taken From Secondary Sources
1.6.5 Key Data Points Taken From Primary Sources
2 Executive Summary (Page No. - 33)
3 Healthcare BPO Market Overview (Page No. - 37)
3.1 Introduction
3.2 History and Evolution
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Introduction of the Patient Protection and Affordable Care Act (Ppaca)
3.3.1.2 Need To Reduce Rising Healthcare Costs
3.3.1.3 Shortage of Skilled Personnel
3.3.2 Restraints
3.3.2.1 Unforeseen Costs
3.3.2.2 Confidentiality and Security of Data Is A Major Concern
3.3.2.3 Loss of Managerial Control
3.3.3 Opportunities
3.3.3.1 Consolidation of the U.S. Healthcare System
3.3.3.2 Icd-10 Conversion
3.4 Market Share
3.5 Porter’s Five Forces Analysis
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Threat From New Entrants
3.5.4 Threat From Substitutes Services
3.5.5 Degree of Competition
3.5.6 Overall Porter’s Analysis
4 Healthcare Payer Outsourcing Market (Page No. - 48)
4.1 Introduction
4.1.1 Drivers
4.1.1.1 Ppaca Will Add Approximately 30 Million Individuals To the American Insurance
4.1.2 Restraints
4.1.2.1 Errors During Client Interaction Could Affect A Company’s Reputation
4.1.3 Opportunities
4.1.3.1 Vendors With Complete Range of Services Attract Insurance Providers
4.2 Claims Processing
4.2.1 Claims Indexing
4.2.2 Claims Investigation
4.2.3 Claims Adjudication
4.2.4 Claims Repricing
4.2.5 Claims Settlement
4.2.6 Litigation Management
4.2.7 Information Management
4.3 Hr Services
4.4 Member Services/Customer Care
4.5 Finance & Accounts
5 Healthcare Provider Outsourcing Market (Page No. - 80)
5.1 Introduction
5.1.1 Drivers
5.1.1.1 Domain Knowledge Helps in Increasing Revenue
5.1.1.2 Increasing Safety of the Processes
5.1.2 Restraints
5.1.2.1 Deteriorating Quality of Service
5.1.2.2 Privacy & Security Concerns
5.1.3 Opportunities
5.1.3.1 Teleradiology
5.1.3.2 Medical Graphics
5.2 Medical Billing
5.3 Medical Coding
5.4 Medical Transcription
5.5 Finance & Accounts
6 Pharmaceutical Outsourcing Market (Page No. - 99)
6.1 Introduction
6.1.1 Drivers
6.1.1.1 Rising Costs and Decreasing Productivity Are Compelling Pharmaceutical Companies To Outsource
6.1.1.2 off-Patenting of Drugs Will Drive the Outsourcing Market
6.1.1.3 Desire To Gain Access To New Technologies, One of the Key Drivers
6.1.1.4 Strategy To Concentrate on Core Competencies & High Margin Products Compels Companies To Outsource
6.1.1.5 Emergence of Biologics To Be One of the Major Drivers in the Future
6.1.2 Restraints
6.1.2.1 Quality Control Issues Limit Outsourcing
6.1.2.2 Differences in the East/West Disease Profiles Inhibits Outsourcing To Specific Regions
6.1.3 Opportunities
6.1.3.1 Outsourcing of Supply Chain & Logistics
6.1.3.2 Outsourcing of Sales & Marketing Functions
6.1.3.3 Outsourcing Medical Writing & Regulatory Functions, A Major Opportunity
6.1.3.4 Emergence of Biologics As A Major Opportunity in the Future
6.2 Cro Market
6.2.1 Drug Discovery
6.2.2 Pre-Clinical
6.2.3 Phase I Clinical
6.2.4 Phase Ii Clinical
6.2.5 Phase Iii Clinical
6.2.6 Phase Iv Clinical
6.2.7 Cdm & Biostatistics
6.2.8 Medical Writing
6.2.9 Regulatory Services
6.2.10 Other Cro Services
6.3 Cmo Market
6.3.1 Api Manufacturing
6.3.2 Formulation & Packaging
6.4 Non-Clinical Services
6.4.1 Scm & Logistics
6.4.2 Sales & Marketing
6.4.2.1 Marketing Kpo/Sales Analytics
6.4.3 Other Non-Clinical Functions
7 Healthcare BPO Market, Geographical Analysis (Page No. - 156)
7.1 Source Geography
7.1.1 U.S.
7.1.1.1 Payer & Provider
7.1.1.2 Pharmaceutical
7.1.2 Europe
7.1.2.1 Payer & Provider
7.1.2.2 Pharmaceutical
7.1.3 Row
7.2 Destination Geography
7.2.1 U.S.
7.2.1.1 Payer & Provider
7.2.1.2 Pharmaceutical
7.2.2 India
7.2.2.1 Payer & Provider
7.2.2.2 Pharmaceutical
7.2.3 Europe
7.2.3.1 Payer & Provider
7.2.3.2 Pharmaceutical
7.2.4 Other Destination Geographies
7.2.4.1 China
7.2.4.2 Philippines
7.2.4.3 Latam
7.2.4.4 Middle East
7.2.4.5 Row
8 Competitive Landscape (Page No. - 209)
8.1 Introduction
8.2 Partnerships, Agreements, Strategic Alliances, and Collaborations
8.3 Expansions
8.4 Acquisitions
8.5 New Product/Service Launches
8.6 Others
9 Healthcare BPO Market, Company Profiles (Page No. - 294)
9.1 Accenture Plc
9.1.1 Overview
9.1.2 Financials
9.1.3 Services
9.1.4 Strategy
9.1.5 Developments
9.2 Accretive Health, Inc.
9.2.1 Overview
9.2.2 Financials
9.2.3 Services
9.2.4 Strategy
9.2.5 Developments
9.3 Anthelio Healthcare Solutions, Inc.
9.3.1 Overview
9.3.2 Financials
9.3.3 Services
9.3.4 Strategy
9.3.5 Developments
9.4 Boehringer Ingelheim Gmbh
9.4.1 Overview
9.4.2 Financials
9.4.3 Services
9.4.4 Strategy
9.4.5 Developments
9.5 Catalent Pharma Solutions, Inc.
9.5.1 Overview
9.5.2 Financials
9.5.3 Services
9.5.4 Strategy
9.5.5 Developments
9.6 Charles River Laboratories International, Inc.
9.6.1 Overview
9.6.2 Financials
9.6.3 Products & Services
9.6.4 Strategy
9.6.5 Developments
9.7 Cognizant Technology Solutions Corporation
9.7.1 Overview
9.7.2 Financials
9.7.3 Services
9.7.4 Strategy
9.7.5 Developments
9.8 Covance, Inc.
9.8.1 Overview
9.8.2 Financials
9.8.3 Services
9.8.4 Strategy
9.8.5 Developments
9.9 Gebbs Healthcare Solutions, Inc.
9.9.1 Overview
9.9.2 Financials
9.9.3 Products & Services
9.9.4 Strategy
9.9.5 Developments
9.10 Genpact Limited
9.10.1 Overview
9.10.2 Financials
9.10.3 Services
9.10.4 Strategy
9.10.5 Developments
9.11 Ibm Corporation
9.11.1 Overview
9.11.2 Financials
9.11.3 Services
9.11.4 Strategy
9.11.5 Developments
9.12 Icon Plc
9.12.1 Overview
9.12.2 Financials
9.12.3 Services
9.12.4 Strategy
9.12.5 Developments
9.13 Infosys Bpo Limited
9.13.1 Overview
9.13.2 Financials
9.13.3 Services
9.13.4 Strategy
9.13.5 Developments
9.14 Igate Patni
9.14.1 Overview
9.14.2 Financials
9.14.3 Products & Services
9.14.4 Strategy
9.14.5 Developments
9.15 Inventiv Health Inc
9.15.1 Overview
9.15.2 Financials
9.15.3 Products & Services
9.15.4 Strategy
9.15.5 Developments
9.16 Lonza Group Ltd.
9.16.1 Overview
9.16.2 Financials
9.16.3 Services
9.16.4 Strategy
9.16.5 Developments
9.17 Medusind Solutions Inc
9.17.1 Overview
9.17.2 Financials
9.17.3 Products & Services
9.17.4 Strategy
9.17.5 Developments
9.18 Mphasis Limited
9.18.1 Overview
9.18.2 Financials
9.18.3 Products & Services
9.18.4 Strategy
9.18.5 Developments
9.19 Omega Healthcare Management Services Pvt Ltd
9.19.1 Overview
9.19.2 Financials
9.19.3 Products & Services
9.19.4 Strategy
9.19.5 Development
9.20 Parexel International Corporation
9.20.1 Overview
9.20.2 Financials
9.20.3 Services
9.20.4 Strategy
9.20.5 Developments
9.21 Patheon Inc
9.21.1 Overview
9.21.2 Financials
9.21.3 Products & Services
9.21.4 Strategy
9.21.5 Developments
9.22 Pharmaceutical Product Development, Inc.
9.22.1 Overview
9.22.2 Financials
9.22.3 Products & Services
9.22.4 Strategy
9.22.5 Developments
9.23 Piramal Enterprises Limited
9.23.1 Overview
9.23.2 Financials
9.23.3 Products & Services
9.23.4 Strategy
9.23.5 Developments
9.24 Quintiles Transnational Holdings, Inc.
9.24.1 Overview
9.24.2 Financials
9.24.3 Services
9.24.4 Strategy
9.24.5 Developments
9.25 Tata Consultancy Services Ltd
9.25.1 Overview
9.25.2 Financials
9.25.3 Products & Services
9.25.4 Strategy
9.25.5 Developments
9.26 Tech Mahindra
9.26.1 Overview
9.26.2 Financials
9.26.3 Products & Services
9.26.4 Strategy
9.26.5 Developments
9.27 Teleradiology Solutions Pvt Ltd.
9.27.1 Overview
9.27.2 Financials
9.27.3 Products & Services
9.27.4 Strategy
9.27.5 Developments
9.28 Wns (Holdings) Limited
9.28.1 Overview
9.28.2 Financials
9.28.3 Services
9.28.4 Strategy
9.28.5 Developments
9.29 Xerox Corporation
9.29.1 Overview
9.29.2 Financials
9.29.3 Products & Services
9.29.4 Strategy
9.29.5 Developments
